Lipid-Lowering Guidelines and Statin Use in CKD: A Time for Change

被引:2
作者
Baber, Usman [1 ]
Muntner, Paul [2 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY USA
[2] Univ Alabama Birmingham, Birmingham, AL 35294 USA
关键词
CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; LDL CHOLESTEROL; RISK EQUIVALENT; PLAQUE; ATHEROSCLEROSIS; METAANALYSIS; OUTCOMES; IMPACT;
D O I
10.1053/j.ajkd.2014.02.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
100201 [内科学]; 100221 [泌尿外科学];
摘要
引用
收藏
页码:736 / 738
页数:3
相关论文
共 18 条
[1]
[Anonymous], 2014, CIRCULATION, DOI DOI 10.1161/01.CIR.0000437738.63853.7A
[2]
Coronary Plaque Composition, Morphology, and Outcomes in Patients With and Without Chronic Kidney Disease Presenting With Acute Coronary Syndromes [J].
Baber, Usman ;
Stone, Gregg W. ;
Weisz, Giora ;
Moreno, Pedro ;
Dangas, George ;
Maehara, Akiko ;
Mintz, Gary S. ;
Cristea, Ecaterina ;
Fahy, Martin ;
Xu, Ke ;
Lansky, Alexandra J. ;
Wennerblom, Bertil ;
Mathey, Detlef G. ;
Templin, Barry ;
Zhang, Zhen ;
Serruys, Patrick W. ;
Mehran, Roxana .
JACC-CARDIOVASCULAR IMAGING, 2012, 5 (03) :S53-S61
[3]
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[4]
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial [J].
Baigent, Colin ;
Landray, Martin J. ;
Reith, Christina ;
Emberson, Jonathan ;
Wheeler, David C. ;
Tomson, Charles ;
Wanner, Christoph ;
Krane, Vera ;
Cass, Alan ;
Craig, Jonathan ;
Neal, Bruce ;
Jiang, Lixin ;
Hooi, Lai Seong ;
Levin, Adeera ;
Agodoa, Lawrence ;
Gaziano, Mike ;
Kasiske, Bertram ;
Walker, Robert ;
Massy, Ziad A. ;
Feldt-Rasmussen, Bo ;
Krairittichai, Udom ;
Ophascharoensuk, Vuddidhej ;
Fellstrom, Bengt ;
Holdaas, Hallvard ;
Tesar, Vladimir ;
Wiecek, Andrzej ;
Grobbee, Diederick ;
de Zeeuw, Dick ;
Gronhagen-Riska, Carola ;
Dasgupta, Tanaji ;
Lewis, David ;
Herrington, William ;
Mafham, Marion ;
Majoni, William ;
Wallendszus, Karl ;
Grimm, Richard ;
Pedersen, Terje ;
Tobert, Jonathan ;
Armitage, Jane ;
Baxter, Alex ;
Bray, Christopher ;
Chen, Yiping ;
Chen, Zhengming ;
Hill, Michael ;
Knott, Carol ;
Parish, Sarah ;
Simpson, David ;
Sleight, Peter ;
Young, Alan ;
Collins, Rory .
LANCET, 2011, 377 (9784) :2181-2192
[5]
Potential Effects of Reclassifying CKD as a Coronary Heart Disease Risk Equivalent in the US Population [J].
Foster, Meredith C. ;
Rawlings, Andreea M. ;
Marrett, Elizabeth ;
Neff, David ;
Grams, Morgan E. ;
Kasiske, Bertram L. ;
Willis, Kerry ;
Inker, Lesley A. ;
Coresh, Josef ;
Selvin, Elizabeth .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) :753-760
[6]
Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non-ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry [J].
Fox, Caroline S. ;
Muntner, Paul ;
Chen, Anita Y. ;
Alexander, Karen P. ;
Roe, Matthew T. ;
Cannon, Christopher P. ;
Saucedo, Jorge F. ;
Kontos, Michael C. ;
Wiviott, Stephen D. .
CIRCULATION, 2010, 121 (03) :357-U33
[7]
Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001
[8]
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[9]
The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment [J].
Hyre, Amanda D. ;
Fox, Caroline S. ;
Astor, Brad C. ;
Cohen, Andrew J. ;
Muntner, Paul .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (01) :37-45
[10]
Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy The YELLOW Trial (Reduction in Yellow Plaque by Aggressive Lipid-Lowering Therapy) [J].
Kini, Annapoorna S. ;
Baber, Usman ;
Kovacic, Jason C. ;
Limaye, Atul ;
Ali, Ziad A. ;
Sweeny, Joseph ;
Maehara, Akiko ;
Mehran, Roxana ;
Dangas, George ;
Mintz, Gary S. ;
Fuster, Valentin ;
Narula, Jagat ;
Sharma, Samin K. ;
Moreno, Pedro R. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (01) :21-29